HONG KONG – In a landmark study, Singapore-based researchers have identified a novel kinase feedback loop controlling autophagy in common RAS-driven cancers and have shown that combining a kinase inhibitor with an agent that prevents autophagy may offer an effective new approach to treating such tumors.